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Abstract
Background: Dengue fever is a rapidly emerging infection throughout the tropics and subtropics with extensive
public health burden. Adequate training of healthcare providers is crucial to reducing infection incidence through
patient education and collaboration with public health authorities. We examined how public sector healthcare
providers in a dengue-endemic region of Ecuador view and manage dengue infections, with a focus on the 2009
World Health Organization (WHO) Dengue Guidelines.
Methods: A 37-item questionnaire of dengue knowledge, attitudes, and practices was developed and administered
to dengue healthcare providers in Machala, Ecuador. Survey focus areas included: “Demographics,” “Infection and
Prevention of Dengue,” “Dengue Diagnosis and the WHO Dengue Guide,” “Laboratory Testing,” “Treatment of Dengue,”
and “Opinions Regarding Dengue.”
Results: A total of 76 healthcare providers participated in this study, of which 82 % were medical doctors and
14 % were nurses. Fifty-eight percent of healthcare professionals practiced in ambulatory clinics and 34 % worked
in a hospital. Eighty-nine percent of respondents were familiar with the 2009 WHO Dengue Guidelines, and, within that
group, 97 % reported that the WHO Dengue Guide was helpful in dengue diagnosis and clinical management.
Knowledge gaps identified included Aedes aegypti mosquito feeding habits and dengue epidemiology. Individuals
with greater dengue-related knowledge were more likely to consider dengue a major health problem. Only 22 % of
respondents correctly reported that patients with comorbidities and dengue without warning signs require hospital
admission, and 25 % of providers reported never admitting patients with dengue to the hospital. Twenty percent of
providers reported rarely (≤25 % of cases) obtaining laboratory confirmation of dengue infection. Providers reported
patient presumptive self-medication as an ongoing problem. Thirty-one percent of healthcare providers reported
inadequate access to resources needed to diagnose and treat dengue.
Conclusion: Participants demonstrated a high level of knowledge of dengue symptoms and treatment, but additional
training regarding prevention, diagnosis, and admission criteria is needed. Interventions should not only focus on
increasing knowledge, but also encourage review of the WHO Dengue Guidelines, avoidance of presumptive
self-medication, and recognition of dengue as a major health problem. This study provided an assessment tool
that effectively captured healthcare providers’ knowledge and identified critical gaps in practice.
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Background
Dengue virus infection is a major cause of morbidity,
mortality, and economic hardship in the tropics and
subtropics [1, 2]. Infection occurs when one of four
dengue virus serotypes (DENV 1–4) are transmitted to
humans by Aedes sp. (primarily Aedes aegypti) mosqui-
toes [1]. Dengue infection may cause fever, headache, ab-
dominal pain, rash, muscle aches, and bone pain (hence
‘break-bone fever’). Infection with additional dengue se-
rotypes increases the risk of hemorrhagic disease, result-
ing in severe mucosal and gastrointestinal bleeding,
hypovolemia, and potentially death [1]. It is crucial that
healthcare professionals are able to accurately diagnose,
monitor, treat, and hospitalize patients infected with
dengue fever.
Latin America has seen a surge of dengue infections
since the 1980s, increasing the need for physicians
skilled in managing dengue. From 2010 to 2014, an aver-
age of 1.5 million cases per year were reported in the
Americas [3], although total case estimates are higher
due to underreporting [2]. Díaz-Quijano et al. [4] esti-
mated that dengue-related mortality rates have tripled
every decade in Latin America since dengue became en-
demic in the 1980s. The economic burden of dengue
fever is also tremendous: the estimated median cost of
dengue treatment in the Americas is US$472 per ambu-
latory case (72.9 % of cases) and US$1,227 per hospital-
ized case [5]. The total economic impact of dengue in
the Americas was estimated at US$2.1 billion per year
(2000–2007 estimate; range US$1–4 billion) [5], under-
scoring the significant economic burden of dengue fever
infection and the need to improve interventions.
Understanding how clinicians manage suspected cases
of dengue is crucial to improving patient outcomes. In
2009, the World Health Organization (WHO) revised its
classification system of dengue severity [6]. The central
aim of the new scheme is to improve clinical outcomes
by identifying patients at highest risk of mortality who
may require therapeutic interventions. However, accept-
ance and incorporation of these recommendations has
varied considerably since publication, with ongoing de-
bate regarding the utility of each classification scheme
[7, 8]. Recent investigations of the WHO Dengue Guide-
lines are promising. Prasad et al. [9] compared the
sensitivity of the 2009 and 1997 WHO guidelines in
identifying the severity of dengue infection among 56
patients who tested positive for dengue infection in
northern India. The study found that, when compared
to the ‘gold standard’ of actual level of medical interven-
tion provided (i.e. outpatient versus inpatient treatment),
the 2009 WHO classification system had 98.0 % sensitiv-
ity, compared to 24.8 % sensitivity using the 1997 sys-
tem. In an analysis of 1,962 cases reviewed from 18
countries, Barniol et al. [10] found that 13.7 % of cases
could not be classified using the 1997 WHO classifica-
tion system, compared to 1.6 % using the 2009 WHO
classification system. As the debate over dengue classifi-
cation continues, it is critical to understand how clini-
cians interpret and apply the guidelines in clinical
practice.
Previous research has focused on how community
members view dengue infections; however, there have
been few attempts to date to better understand the per-
spectives of clinicians. These studies have been con-
ducted mainly in Asia [9, 11–15], with a single study
performed in Puerto Rico [16]; to our knowledge, no
studies to date have been conducted in Central or South
America. Results have varied considerably across these
studies. In a study of Sri Lankan practitioners [11],
Kularatne et al. report significant disagreement among
physicians over the utility of treating dengue with ste-
roids, antibiotics, and platelet transfusions. Lee et al.
[12] noted that clinical practice varied significantly by
practice setting, as physicians practicing in private prac-
tice were more likely to refer patients with dengue to
the hospital and to utilize dengue PCR testing (vs. ser-
ology), compared to physicians practicing at public
clinics. Thaver et al. [13] conducted a knowledge-based
assessment in Pakistan and found that practitioners had
a stronger understanding of dengue pathophysiology
than clinical diagnosis and treatment. Together, these
studies provide evidence that clinical practice varies by
region and over time, making it crucial to understand
local, current practices for dengue management when
identifying areas of potential improvement.
As the epidemiology of dengue has evolved over the
past century, so have healthcare systems’ strategies to re-
duce infection rates. Healthcare providers who interact
directly with patients have an important role in both
treating and preventing the spread of dengue. This study
was conducted to assess the knowledge, attitudes, and
practices regarding dengue infection among healthcare
providers in a dengue-endemic city in Ecuador. We also
assessed familiarity with the 2010 Pan American Health
Organization’s (PAHO) Spanish translation [17] of the
2009 WHO Dengue Guidelines, and how these guide-
lines influenced their clinical practice, providing import-
ant information to help guide future interventions.
Methods
Study site and study population
We conducted a study of the knowledge, attitudes, and
practices associated with dengue infection among
healthcare providers practicing in Machala, Ecuador,
from December, 2013 through December, 2014. Machala
is an urban coastal city located in El Oro Province,
Ecuador (3.2667°S, 79.9667°W, altitude 6 m, population
245,972), and has been well-described as hyper-endemic
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for dengue fever (DENV 1–4) [18, 19]. Over a five year
period (2010 to 2014), 72,060 cases of dengue were re-
ported in Ecuador, with an annual average of 14,412
cases [20]. This study is part of an ongoing collaboration
with the Ministry of Health to strengthen dengue surveil-
lance capacities, with the aim of studying public sector
healthcare providers; private physicians were therefore not
included in our study. The Ecuadorian Ministry of Health
previously collaborated with the Pan American Health
Organization (PAHO) to translate the 2009 WHO Dengue
Guidelines into a 2010 Spanish version of the guidelines
[17], which was distributed throughout Machala and
serves as a focal point of our study.
Physicians and nurses were recruited as the study
population because they serve as the frontline healthcare
workers for diagnosis and treatment of dengue and other
febrile illnesses. Healthcare providers in Machala include
primary care providers working in local healthcare
clinics (Centros de Salud) and tertiary care providers
practicing in public and private hospitals, including
emergency care physicians, hospitalists, and subspecial-
ists. The public health system requires that individuals
visit a single assigned Centro de Salud prior to referral
to hospital subspecialists. These clinics provide care free
of charge. Private clinics were not included in this study.
It is common for Ecuadorians to view hospital care as
superior to ambulatory clinics, leading some patients to
seek primary care in the Emergency Department.
Participant recruitment
Two methods of recruitment were utilized in this study.
Participants from the public health sector were recruited
at dengue management training conferences in Machala,
with survey distribution prior to the educational session.
These trainings were conducted in collaboration with
and sponsored by the Ecuadorian Ministry of Health and
the Global Emerging Infections Surveillance and Re-
sponse System (GEIS, a division of the United States
Armed Forces Health Surveillance Center), with the goal
of improving recognition of dengue infection and aware-
ness of the World Health Organization’s Clinical Manual
of Dengue. These individuals were recruited for the
training sessions as they play key roles in dengue man-
agement. The second form of recruitment involved visits
to the Ministry of Health public health clinics and to the
Teófilo Dávila Hospital, the reference hospital for the
province of El Oro.
Questionnaire development
We developed a 37-item questionnaire, with the goal of
evaluating the knowledge, attitudes, and practices associ-
ated with dengue infection among healthcare providers.
Information regarding dengue infection was based on
the World Health Organization’s Clinical Manual of
Dengue, with a subset of questions on local dengue
epidemiology based on peer-reviewed sources [3, 13,
18]. The questionnaire comprised of the following sec-
tions: “Demographics,” “Infection and Prevention of
Dengue,” “Dengue Diagnosis and the WHO Guide,”
“Laboratory Testing,” “Treatment of Dengue,” and
“Opinions Regarding Dengue” (See Additional file 1:
Appendice A1 for English and Additional file 2:
Appendice A2 for Spanish versions of the survey in-
strument). The survey was piloted through face-to-face
interviews with physicians in Machala prior to con-
ducting the full study.
Data analysis
Survey responses were analyzed using R (Version 3.1.2).
Descriptive statistics (e.g. means, medians, frequency
distributions) were calculated. A Cumulative Knowledge
Score (CKS) was calculated as an aggregate of all
knowledge-based questions (See questions in Tables 2
and 3). Correct answers received one point and incorrect
answers received zero points, for a maximum possible
score of 14 points. Questions requiring participants to
select multiple correct answer choices were given one
point per correct answer selected. A Clinical Scenario
Score (CSS) was similarly developed from three clinical
questions, with a maximum score of three points (See
Table 3). These same clinical questions were included in
the CKS. Bivariate Pearson Correlations (r) were con-
ducted to assess whether the CSS and CKS were associ-
ated with awareness and/or support of WHO clinical
guidelines, prior training, years of experience or number
of patients treated, and region of medical practice. We
also examined whether dengue risk perceptions were as-
sociated with support for the WHO dengue guidelines,
and the proportion of patients referred for dengue la-
boratory testing or hospital admission. The questions
were grouped by dependent variable, and a Bonferroni
correction was used for multiple comparisons. The alpha
level was set at 0.05 (i.e., values of p <0.05 were consid-
ered statistically significant).
Closed-ended questions using a Likert scale and open-
ended questions were used to assess doctor and patient
perceptions of dengue (See Tables 5, 6 and 7). The fre-
quencies of these themes were tabulated, and for each
theme, and the average scores from the Likert scale were
used to identify themes that associated with greater risk
perceptions.
Results/Discussion
In this study, several common themes emerged; health-
care providers reported:
1. High use and awareness of the 2009 WHO Dengue
Management Guidelines.
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2. High level of knowledge regarding dengue signs and
symptoms, but demonstrated significant knowledge
gaps regarding dengue epidemiology and prevention.
3. Limited knowledge of WHO-recommended criteria
for dengue hospital admission, and under-utilization
of confirmatory laboratory tests.
4. High level of concern regarding the burden of
dengue in Machala; and a lack of training and basic
tools needed to adequately diagnose and manage
dengue infections.
5. High levels of presumptive self-medication and delay
in seeking medical attention among patients with
dengue fever.
This study assessed the knowledge, attitudes and prac-
tices of local healthcare providers in dengue manage-
ment. This study was restricted to one group of
healthcare practitioners in Machala at one point in time,
and accordingly, the small sample size of available pro-
viders within Machala may limit generalizability of
findings. Additionally, data collected were self-reported,
limiting our ability to assess healthcare practices and
causal inference. However, this study captures useful in-
formation from a community with a high burden of den-
gue, and this assessment framework can inform dengue
management in other settings.
Demographics
A total of 76 healthcare providers involved in dengue
care and treatment in Machala, Ecuador, participated in
the study. Demographic information is presented in
Table 1. Surveys were administered to participants dur-
ing visits to their offices or at training events, resulting
in a 100 % response rate. Forty-one percent of partici-
pants were male and 59 % were female. Ages ranged
from under 30 years old to less than 70 years old, with a
median age group of 41 to 50 years old and a median of
10 to 14 years of healthcare experience. Participants
consisted of physicians (82 %), nurses (14 %), and other
healthcare professionals (4 %). There are 93 physicians
working in the public health sector in Machala including
63 doctors at 17 public health clinics, 15 in the central
hospital, and 15 in the social security hospital, giving an
inclusion rate of 67 % of all potential physician subjects
in the city. Healthcare providers worked primarily in
public health clinics (58 %) and the Teófilo Dávila
Hospital (34 %).
Healthcare provider views of dengue burden
As seen in Table 2, healthcare providers in Machala were
concerned with dengue infections, with 89 % of partici-
pants agreeing that it is a “major problem for my patient
population”. Of those in agreement, the majority re-
ported that dengue is a significant threat because the
virus is endemic to the region and has the potential to
cause high morbidity. One participant reported that den-
gue may cause “the deterioration of the [individual],
family and community health”. The majority of respon-
dents (78 %) also agreed with the statement, “My pa-
tients feel that dengue infection is a major problem for
their health,” with 34 % citing health complications and
Table 1 Characteristics of Study Participants (n = 76)
Category Response selected n (%)
Gender Male 31 (41 %)
Female 45 (59 %)
Age (years) <30 24 (32 %)
31–40 10 (14 %)
41–50 17 (23 %)
51–60 17 (23 %)
61–70 6 (8 %)
>70 0 (0 %)
Medical role Doctor 62 (82 %)
Nurse 11 (14 %)
Other 3 (4 %)
Years of Medical experience <1 6 (8 %)
1–4 26 (34 %)
5–9 5 (7 %)
10–14 7 (9 %)
15–19 10 (13 %)
>19 22 (29 %)
Practice setting (n = 74) Community Health Center
(Subcentro de Salud)
43 (58 %)
Hospital 25 (34 %)
Diagnostic Laboratory 2 (3 %)
Other 4 (5 %)
Table 2 Physician responses to the statement “I think that
dengue is a major problem for my patient population” (n = 71)
Categorical responses Open-ended responses
Agree or Strongly Agree
(n = 63, 88 %)
The region is an endemic zone
Dengue has a high morbidity
There is a lack of preventative measures
Patients self-medicate
There exists poor infrastructure
Dengue poses a high risk to others
There is a lack of education about dengue
There is a lack of social consciousness
regarding dengue
Neutral (n = 4, 6 %) There is adequate education about dengue
Disagree or Strongly
Disagree (n = 4, 6 %)
Good preventative measures are in place
Good medical attention is available
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mortality as the major concerns in the general population.
Seventeen percent of participants suggested that public
health measures within the city, including disease preven-
tion efforts, local infrastructure, and education were
inadequate for controlling disease transmission. A small
subset (6 %) of providers reported that dengue is not a
major problem because the region already has effective
prevention and treatment interventions in place. A similar
proportion of providers also felt that a dengue diagnosis
creates an unnecessary sense of fear among patients.
Providers’ views of the community response to dengue
and self-medication
The majority (76 %) of healthcare providers perceived
that patients exhibiting symptoms of dengue would seek
attention at a healthcare facility. An equal proportion
also reported that patients are aware of the steps needed
to prevent dengue infection (See Tables 2, 3 and 4 for
physician attitudes toward dengue); of those who agreed
with this statement, 30 % suggested that public health
awareness campaigns were successful. For example, one
participant reported, “due to constant [educational] cam-
paigns, [patients] know to seek out medical help before
they develop alarms signs”.
Seventeen percent of providers reported that upon
symptom onset, many patients “turn to self-medication
and do not seek out professional help”. Previous studies
have reported that communities in the urban periphery,
and particularly men, report self-medicating to treat
dengue [21]. This tendency to self-medicate can result in
greater dengue morbidity and mortality due to lack of
clinical management, and has the potential to increase
community susceptibility to other diseases by promoting
bacterial resistance to over-prescribed antibiotics.
Clinical scenario scores and cumulative knowledge scores
The Cumulative Knowledge Score analysis results are
presented in Tables 5 and 6 (Table 6 consists of the
Clinical Scenario subset of questions). The mean Cumu-
lative Knowledge Score was 10.5 of 14 possible points
(SD ± 1.73). Using a Bonferroni correction, the statistical
significance level for CKS was determined to be p <0.01.
The Cumulative Knowledge Score correlated positively
with: 1) reporting familiarity with the WHO Dengue
Guide (r = 0.427, p <0.01), 2) agreeing with the statement
“I believe that dengue is a major problem for my patient
population” (r = 0.433, p <0.01), and 3) agreeing to the
statement “My patients feel that dengue infection is a
major problem for their health” (r = 0.282, p <0.01). Not-
ably, having previous dengue training was not significantly
correlated with the CKS (p = 0.225). These associations
provide evidence of the interrelatedness of a practitioner’s
knowledge, patient care, and concern for dengue infection.
Clinician education must not only focus on basic know-
ledge, but also emphasize dengue’s burden on individual
health and communities.
The Clinical Scenario Score analysis results are pre-
sented in Table 6. The mean Clinical Scenario Score was
2.1 of 3 potential points (Table 6). Using a Bonferroni
correction, the statistical significance level for CSS was
determined to be p <0.0125. A higher CSS was corre-
lated with the following responses: 1) reporting familiar-
ity with WHO Dengue Guidelines (r = 0.326, p <0.01), 2)
agreeing with the statement “I believe that dengue is a
major problem for my patient” (r = 0.37, p <0.01), 3)
agreeing with the statement “I am fully trained to man-
age a patient with an infection of dengue without warn-
ing signs,” (r = 0.383, p <0.01), and 4) agreeing with the
statement “In my experience, a community member who
has dengue symptoms will seek medical attention” (r =
0.453, p <0.01). Higher CSS was also associated with
reporting that the WHO Guidelines are helpful, although
this was not statistically significant after a Bonferroni cor-
rection was applied (r = 0.245, p <0.05). These findings
emphasize the importance of practitioner ‘buy-in’ of
Table 3 Physician responses to the statement “My patients feel
that dengue infection is a major problem for their health” (n = 68)
Categorical responses Open-ended responses
Agree or Strongly Agree
(n = 53, 78 %)
Dengue has a high morbidity
Dengue is considered an alarming diagnosis
Dengue decreases economic productivity
Dengue is difficult to detect
The environment is conducive to disease
transmission
Dengue poses a high risk to others
Neutral (n = 7, 10 %) Adequate medical attention is available
Disagree or Strongly
Disagree (n = 8, 12 %)
Patients believe self-medication is adequate
There is a lack of education about dengue
Table 4 Physician responses to the statement “In my experience,
a member of the community who exhibits dengue symptoms will
seek medical attention” (n = 71)
Categorical responses Open-ended responses
Agree or Strongly Agree
(n = 54, 76 %)
Patients believe that dengue has a high
morbidity if untreated
Dengue symptoms are severe
Patients want to prevent complications
There is adequate education about dengue
There is easy access to medical attention
Neutral (n = 7, 10 %) Some patients will seek attention while others
self-medicate
Disagree or Strongly
Disagree (n = 10, 14 %)
Patients do not seek medical attention until
complications develop
Medical care is delayed by self-treatment
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Table 5 Knowledge-Based Questions (n = 76)
Question Correct response n (%) with correct response
1. How is dengue spread? Aedes mosquito 75 (99 %)
2. At what time of day are people most likely to be
infected by dengue?
Any answer other than “Night” 57 (75 %)
3. Which of the dengue serotypes have been found in
Ecuador?
DENV 1–4 are all present
- Note: 0.25 point given per correct answer, with a total of
1 point available
DENV 1 54 (71 %)
DENV 2 54 (71 %)
DENV 3 48 (63 %)
DENV 4 34 (45 %)
4. What advice do you give your patients to prevent
dengue infection?
- Note: Question is worth a total of 2 points
- 0.25 point given per correct answer, with a maximum of
1 point. Column to the right indicates the n (%) of
respondents receiving
- 1 point given for not selecting “Take Paracetamol”
1. Frequently change the water in flower vases 66 (87 %)
2. Remove containers that accumulate clean water 69 (91 %)
3. Eliminate tanks or puddles with stagnant water 55 (72 %)
4. Keep drinking water containers (cisterns, tanks) tightly
closed
67 (88 %)
Did not select “Take Paracetamol” 54 (71 %)
5. Which group of patients should be hospitalized?
- Note: Each response is worth 1 point. Question is worth
a total of 4 points
- If the answer is correctly selected, the respondent gains
1 point
- If the answer is correctly left blank, the respondent gains
1 point
- Responses that are correct are marked here as (T) and if
incorrect are marked as (F)
1. Dengue without warning signs (F) 76 (100 %)
2. Dengue without warning signs but with comorbidities (T) 17 (22 %)
3. Dengue with warning signs (T) 59 (78 %)
4. Severe dengue (T) 58 (76 %)
Percent answering all 4 correctly 15 (20 %)
6. According to the WHO’s 2010 Clinical Management of
Dengue guidebook, what signs and symptoms can be
used to identify an infection of dengue without alarm
signs?
Correct Responses n (%) selecting response
- Note: Question is worth 1 point
- Each response is worth 1/19 point, which is given for
either correctly selecting a true response or correctly
leaving a false response blank
Headache 59 (78 %)
Muscle pain 60 (79 %)
Retro-orbital pain 62 (82 %)
Positive tourniquet test 45 (59 %)
Fever/subjective warmth 64 (84 %)
Petechial rash 33 (43 %)
Vomit 25 (33 %)
Incorrect
Ascites 1 (1 %)
Constipation 5 (7 %)
Diarrhea 10 (13 %)
Dyspnea 3 (4 %)
Dysuria 2 (3 %)
Chest pain 1 (1 %)
Edema 2 (3 %)
Icterus 1 (1 %)
Lymphadenitis 3 (4 %)
Nasal secretions 11 (14 %)
Persistent cough 3 (4 %)
Thrombocytopenia 15 (22 %)
Oral Hydration 70 (92 %)
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dengue’s detrimental impact, as clinical knowledge and
concern for dengue infections are strongly associated. Of
note, the clinical scenarios comprised a small component
(3 of 14 points) of the above-mentioned Cumulative
Knowledge Score.
Providing patients with accurate dengue prevention and
treatment guidance
Although study participants demonstrated a high level
of understanding of dengue infection signs, symptoms,
and treatment, we identified specific gaps in knowledge
of dengue prevention and epidemiology. A total of 29 %
of participants incorrectly selected “take paracetamol” as
a method for preventing dengue infection (Table 5). Al-
though it is possible that some participants misinterpreted
this question as asking which medications may help man-
age dengue, the survey clearly asked how dengue may be
prevented, indicating a misconception of prevention strat-
egies. In addition, 25 % incorrectly selected “night time” as
the most likely feeding time for Aedes mosquitoes. Similar
findings have been documented elsewhere: Huang et al.
[14] found that only 14.4 % of Taiwanese providers cor-
rectly identified Aedes mosquito feeding habits, compared
to 82.8 % who correctly identified Anopheles mosquito
feeding habits. When participants were asked which dengue
virus serotypes are found in Ecuador, only 38 % correctly
answered all four serotypes (DENV 1–4). Ho [15] also
found limited knowledge of dengue epidemiology among
healthcare providers in Taiwan, with only 47.7 % correctly
responding that dengue is endemic in that country. These
Table 5 Knowledge-Based Questions (n = 76) (Continued)
7. Select any the treatments you could use in a patient
suspected to have dengue
- Note: Question is worth 1 point
- 0.5 points given for hydration (either oral and/or IV) and
0.5 points given for paracetamol. Recipient is given 0
points if anti-bacterial or anti-viral medication is selected
IV Hydration 12 (16 %)
Paracetamol 71 (93 %)
Anti-bacterial 1 (1 %)
Anti-viral 1 (1 %)





Note: One point given per question, unless otherwise specified
Table 6 Clinical Knowledge Questions
Question Response Selected n (%)
1. An 8-year old male patient presents to your office with a
4 day history of fever, nausea, vomiting three times per day,
and joint aches. He is accompanied by his mother, who
reports that he has been less active over the past few days
and seems to be getting more uncomfortable. You note the
following abnormalities on physical exam: The patient has
bleeding of the oral mucosa, a palpable mass on the right side
2 cm below the ribs, and winces when you palpate his
abdomen. You do not observe fluid in the abdomen or
difficulty breathing. Based on current WHO guidelines, this
patient is best classified as:
(n = 73)
Dengue fever 0 (0 %)
Dengue hemorrhagic fever 5 (7 %)
Dengue shock syndrome 0 (0 %)
Dengue without warning signs 2 (3 %)
Dengue with warning signs (T) 61 (83 %)
Severe dengue 5 (7 %)
2. A 5-year-old girl patient presents to your office with a few
days of fever and a distended, painful abdomen. Her mother
states that she has been less active over the past 3 days. It is
currently February and you have seen six patients in the past
3 weeks with dengue infections. The best course of action in
managing this patient is to:
(n = 73)
Order dengue lab tests, tell the patient to get rest at home,
and ask the patient to return to your office in 24 h
10 (14 %)
Order dengue lab tests and admit the patient to the hospital
for 24 h of observation (T)
54 (74 %)
Order dengue lab tests and admit the patient to the Intensive
Care Unit for close monitoring and access to emergency care
9 (12 %)
3. A 27-year-old male patient presents to your office in February
with two days of fever and complaints of muscle aches. He
notes that he has had three episodes of non-bloody vomiting
in the past two days. The patient notes that his younger sister
has similar symptoms. You recall hearing numerous reports of
dengue infection during the last month. The best course of
action in managing this patient is to:
(n = 71)
Order dengue lab tests, tell the patient to get rest at home,
and ask the patient to return to your office in 24 h (T)
52 (73 %)
Order dengue lab tests and admit the patient to the hospital
for 24 h of observation
19 (27 %)
Order dengue lab tests and admit the patient to the ICU for
close monitoring and access to emergency care
0 (0 %)
Note: Each question is worth 1 point. (T) if placed next to the correct response
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misunderstandings may lead healthcare providers to give
patients incorrect, clinically significant advice. It is critical
to target specific local misconceptions of dengue preven-
tion and transmission through training of medical profes-
sionals, in order to reduce the burden of dengue.
Confusion regarding hospital admission criteria
Clinicians indicated confusion when developing appropriate
dengue treatment plans for their patients. When healthcare
professionals were asked which groups of patients with
dengue require hospital admission, only 22 % correctly
stated that patients with “dengue without warning signs but
with comorbidities” require hospital admission (Table 5).
The 2009 WHO Dengue Guidelines provide specific rec-
ommendations for appropriate clinical observation based
on a patient’s risk of significant morbidity [7]. These guide-
lines state that any patient with a comorbidity (e.g. diabetes
mellitus, obesity, risk of hemorrhage such as peptic ulcer
disease) should be admitted to a hospital during a dengue
infection, regardless of the severity of infection. Addition-
ally, only 45 % of participants correctly responded to all
three clinical scenarios (Table 6), demonstrating knowledge
gaps of patient admission criteria.
Hospital admission rates for dengue infection vary con-
siderably between regions globally. For example, Toma-
shek et al. [16] found that only 31 % of Puerto Rican
medical providers used hospital admission criteria consist-
ent with the 1997 WHO Dengue Guidelines. Conversely,
Lee et al. [12] reported that one-third of providers in
Singapore “always” or “often” admitted patients with sus-
pected dengue, regardless of infection severity. Globally, it
is estimated that less than 5 % of patients infected with
dengue will develop severe disease [22], and WHO recom-
mends that patients who do not meet criteria for
hospitalization have frequent office follow-up [7]. This is
particularly important in resource-limited settings. Pa-
tients with comorbidities who are not admitted to hospi-
tals may have worse clinical outcomes, underscoring the
need for close monitoring of this patient population.
Diagnostic testing: under-utilization and inadequate
resources
Study participants indicated suboptimal use of confirma-
tory diagnostic laboratory tests when dengue infection
was suspected (Table 7). As appropriate in a region with
many acute febrile illnesses with similar clinical presen-
tations as dengue, 61 % of healthcare providers reported
referring all patients with suspected dengue infection for
laboratory test confirmation. However, 20 % of partici-
pants reported referring patients for confirmatory la-
boratory tests 25 % of the time or less. As these patients
may actually be infected with other febrile illnesses such
as leptospirosis, malaria, or chikungunya, laboratory
confirmation is crucial for differential diagnosis and to
inform appropriate medical interventions. It is important
to note that 14 % of providers reported inadequate ac-
cess to diagnostic testing for dengue (Table 7). Addition-
ally, providers who agreed with the statement “I am fully
trained to manage a patient with an infection of dengue
without warning signs” referred a higher percentage of
their patients for laboratory testing (r = 0.345, p <0.01),
compared to those who disagreed with this statement.
This may signal one of two possibilities: clinical confi-
dence is increased with better access to diagnostic
Table 7 Practice-Based Questions
Question Response selected n (%)
Approximately how many patients do
you see per week? (n = 60)
0 3 (5 %)





>150 7 (11.7 %)
Are you familiar with the WHO’s 2010
Clinical Management of Dengue
guidelines?
Yes 67 (89 %)
No 8 (11 %)
Do you feel that the WHO’s Dengue
guidelines help in managing dengue?
Yes 64 (97 %)
No 2 (3 %)
Of those patients who you suspect
have dengue fever, approximately
what percentage do you refer to a lab
for diagnostic testing?
0 % of patients 1 (1 %)
10 % of patients 10 (15 %)
25 % of patients 3 (4 %)
50 % of patients 8 (12 %)
75 % of patients 5 (7 %)
100 % of patients 40 (61 %)
Do your patients ever use a private lab
without a referral?
Yes 31 (47 %)
No 35 (53 %)
Approximately what percentage of
patients with dengue fever do you
refer to the hospital for additional
medical treatment?
0 14 (26 %)
<10 % 31 (57 %)
25 % 1 (2 %)
50 % 6 (11 %)
75 % 1 (2 %)
100 % 1 (2 %)
Do you feel you have adequate
resources to treat your patients when
they have dengue?
Yes 48 (69 %)
No 22 (31 %)
If you said ‘No’ to the previous
question, what are you lacking?
- Note: Percentages given as n/22,
based on previous question
- Note: Subjects may select multiple
options







Access to lab tools 10 (45 %)
Note: Percentages given do not include respondents who did not answer
the question
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testing, or providers who report greater confidence in
their clinical training refer more patients for confirma-
tory laboratory tests. Access to dengue diagnostic testing
remains a key issue in this context.
Healthcare providers were asked about availability and
access to a variety of resources for dengue diagnosis and
treatment. A total of 31 % of providers reported having in-
adequate resources (See Table 7 for specific resources).
There were no significant correlations between reported
lack of resources for dengue diagnosis and treatment and
insufficient training, Cumulative Knowledge Scores, treat-
ments used, or other items from this survey. Identifying
the impact of resource deficiencies is difficult to assess
from the data collected, as no discernible differences in
knowledge, attitudes, or practices were identified in this
study. Further investigation of availability and access to re-
sources for dengue diagnosis and treatment, and how they
influence daily clinical practice is needed.
Awareness and Implementation of the WHO dengue
guidelines
Awareness of the 2009 WHO Dengue Guidelines was
high, with 89 % of participants reporting previous know-
ledge of the guidelines. Of these respondents, 97 % re-
ported that these guidelines were helpful. This finding is
in contrast to Kularatne’s study of Sri Lankan practi-
tioners [13], in which only 45 % of practitioners reported
using the WHO Dengue Guidelines. However, Kular-
atne’s study was conducted prior to the current version
of the WHO Dengue Guidelines, and may be more re-
lated to local medical practices and training.
Impact of practice setting
In this study, there were no significant differences in re-
ported knowledge, attitudes, and practice, between health-
care providers practicing in a hospital versus ambulatory
settings, including familiarity with the 2009 WHO Dengue
Guidelines, reporting that these guidelines were helpful,
or overall dengue knowledge (p >0.05). Previous studies
have indicated that practice settings can influence clinical
management of dengue fever. Ho et al. [15] found that
healthcare providers practicing at Taiwanese medical cen-
ters (i.e. medical school-affiliated hospitals at the highest
accreditation level) had significantly different levels of
knowledge, compared to providers at non-medical centers.
In order for dengue interventions to be most effective in
hyper-endemic regions, healthcare providers of all types
and at all settings must receive adequate training and
guidance, and differences in knowledge, attitudes, and
practice by setting should continue to be assessed.
Conclusion
Findings from this study provide important insights into
medical practitioner knowledge, attitudes, and practices
associated with dengue fever in a resource-limited en-
demic region. These findings highlight several strategies
to improve diagnosis and clinical management of dengue
infections in this region. A strong healthcare policy be-
gins with accurate information, which can best be ob-
tained and disseminated through close collaboration
between the public, primary healthcare providers, health
educators, and the public health sector.
 Healthcare providers should receive continuous
education about dengue prevention, transmission,
and high-risk patient populations.
 Providers’ needs should be assessed in future studies,
as nearly one-third of participants reported inadequate
access to crucial healthcare resources.
 Health providers should educate their patient
population about the harms of self-diagnosis and
presumptive self-medication.
 Findings demonstrated that those providers who
showed the greatest concern of dengue infections
were also the most knowledgeable and provided
clinical care that more closely aligned with WHO
recommendations. Future interventions should
therefore provide core dengue information while
emphasizing dengue’s impact on health and
development.
 Periodic reassessment of the local knowledge,
attitudes, and clinical practices will be instrumental
to reduce the burden of dengue fever and improve
clinical management in high-burden settings.
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